日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and molecular characteristics, therapeutic strategies, and prognosis of non-small cell lung cancer patients harboring primary and acquired BRAF mutations

携带原发性和获得性BRAF突变的非小细胞肺癌患者的临床和分子特征、治疗策略和预后

Feng, Xiangran; Zeng, Ran; Lyu, Mengchen; Chen, Xiaoyan; Xu, Ziwei; Hu, Yue; Bao, Zhiyao; Sun, Xianwen; Zhao, Jingya; Zhou, Ling; Zhou, Jun; Gao, Beili; Dong, Lei; Xiang, Yi

A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)

CHOICE-01试验中托瑞普利单抗联合化疗治疗晚期非小细胞肺癌(NSCLC)的结果简明语言总结

Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yenpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Tang, Xiongwen; Yu, Jianjun; Maher, Ellen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Wang, Jie

Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial

托瑞普利单抗联合化疗一线治疗晚期非小细胞肺癌(CHOICE-01):一项随机、双盲、3期试验的最终总生存期和生物标志物探索

Zhong, Jia; Fei, Kailun; Wu, Lin; Li, Baolan; Wang, Zhijie; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yunpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Yao, Sheng; Yu, Jianjun; Cai, Shang Li; Cai, Yiran; Xu, Jiachen; Zhuang, Wei; Luo, Xianmin; Duan, Jianchun; Wang, Jie

Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study

卡瑞利珠单抗联合卡铂和培美曲塞作为晚期非鳞状非小细胞肺癌一线治疗:CameL随机3期研究的5年结果

Zhou, Caicun; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, LiZhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, QiMing; Cheng, Ying; Wu, Fengying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, XiaoRong; Jin, Faguang; Gao, Hongjun; An, Guangyu; Ding, Cuimin; Jiang, Xiaodong; Xiong, Jianping; Zhou, Xiangdong; Hu, Sheng; Lu, Ping; Liu, Anwen; Guo, Shuliang; Huang, Jianjin; Zhu, Chengchu; Zhao, Jian; Gao, Beili; Chen, Yinglan; Hu, Chengping; Zhang, Jian; Zhang, Hongmei; Zhao, Hui; Wang, Zhigao; Ma, Xinjing; Shi, Wei

Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities

原发性肺癌与血液系统恶性肿瘤共存的新趋势:临床病理特征和遗传异常的综合分析

Lyu, Mengchen; Luo, Lifeng; Zhou, Ling; Feng, Xiangran; Yang, Jin; Xu, Ziwei; Sun, Xianwen; Bao, Zhiyao; Wang, Xiaofei; Gao, Beili; Xiang, Yi

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

托瑞普利单抗联合化疗治疗初治晚期非小细胞肺癌患者:一项多中心随机 III 期试验 (CHOICE-01)

Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yunpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Tang, Xiongwen; Yu, Jianjun; Maher, Ellen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Wang, Jie

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

中国肺癌骨转移诊断和治疗专家共识(2022版)

Duan, Jianchun; Fang, Wenfeng; Xu, Hairong; Wang, Jinliang; Chen, Yuan; Ding, Yi; Dong, Xiaorong; Fan, Yun; Gao, Beili; Hu, Jie; Huang, Yan; Huang, Cheng; Huang, Dingzhi; Liang, Wenhua; Lin, Lizhu; Liu, Hui; Ma, Zhiyong; Shi, Meiqi; Song, Yong; Tang, Chuanhao; Wang, Jialei; Wang, Lifeng; Wang, Yongfeng; Wang, Zhehai; Yang, Nong; Yao, Yu; Yu, Yan; Yu, Qitao; Zhang, Hongmei; Zhao, Jun; Zhao, Mingfang; Zhu, Zhengfei; Niu, Xiaohui; Zhang, Li; Wang, Jie

International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease

关于肺癌合并慢性阻塞性肺疾病的诊断和治疗的国际专家共识

Zhou, Chengzhi; Qin, Yinyin; Zhao, Wei; Liang, Zhenyu; Li, Min; Liu, Dan; Bai, Li; Chen, Yahong; Chen, Yan; Cheng, Yuan; Chu, Tianqing; Chu, Qian; Deng, Haiyi; Dong, Yuchao; Fang, Wenfeng; Fu, Xiuhua; Gao, Beili; Han, Yiping; He, Yong; Hong, Qunying; Hu, Jie; Hu, Yi; Jiang, Liyan; Jin, Yang; Lan, Fen; Li, Qiang; Li, Shuben; Li, Wen; Li, Yaqing; Liang, Wenhua; Lin, Gen; Lin, Xinqing; Liu, Ming; Liu, Xiaofang; Liu, Xiaoju; Liu, Zhefeng; Lv, Tangfeng; Mu, Chuanyong; Ouyang, Ming; Qin, Jianwen; Ren, Shengxiang; Shi, Huanzhong; Shi, Minhua; Su, Chunxia; Su, Jin; Sun, Dejun; Sun, Yongchang; Tang, Huaping; Wang, Huijuan; Wang, Kai; Wang, Ke; Wang, Mengzhao; Wang, Qi; Wang, Wei; Wang, Xiaoping; Wang, Yuehong; Wang, Zhijie; Wang, Zirui; Wu, Lin; Wu, Di; Xie, Baosong; Xie, Min; Xie, Xiaohong; Xie, Zhanhong; Xu, Shufeng; Xu, Xiaoman; Yang, Xia; Yin, Yan; Yu, Zongyang; Zhang, Jian; Zhang, Jianqing; Zhang, Jing; Zhang, Xiaoju; Zhang, Yingying; Zhong, Diansheng; Zhou, Qing; Zhou, Xiangdong; Zhou, Yanbin; Zhu, Bo; Zhu, Zhengfei; Zou, Chenxi; Zhong, Nanshan; He, Jianxing; Bai, Chunxue; Hu, Chengping; Li, Weimin; Song, Yong; Zhou, Jianying; Han, Baohui; Varga, Janos; Barreiro, Esther; Park, Hye Yun; Petrella, Francesco; Saito, Yuichi; Goto, Taichiro; Igai, Hitoshi; Bravaccini, Sara; Zanoni, Michele; Solli, Piergiorgio; Watanabe, Satoshi; Fiorelli, Alfonso; Nakada, Takeo; Ichiki, Yoshinobu; Berardi, Rossana; Tsoukalas, Nikolaos; Girard, Nicolas; Rossi, Antonio; Passaro, Antonio; Hida, Toyoaki; Li, Shiyue; Chen, Liang'an; Chen, Rongchang

SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients

SDH突变作为小细胞肺癌患者化疗预后的潜在预测因子

Zeng, Ran; Fan, Xiaoyun; Yang, Jin; Fang, Chen; Li, Jieyi; Wen, Wei; Liu, Jing; Lv, Mengchen; Feng, Xiangran; Zhao, XiaoKai; Yu, Hongjie; Zhang, Yuhuan; Sun, Xianwen; Bao, Zhiyao; Zhou, Jun; Ni, Lei; Wang, Xiaofei; Cheng, Qijian; Gao, Beili; Gong, Ziying; Zhang, Daoyun; Dong, Yuchao; Xiang, Yi

The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC

阿帕替尼和培美曲塞联合用药对非小细胞肺癌具有抗肿瘤和抗血管生成作用。

Zhou, Ling; Zhang, Wenchao; Xiang, Yi; Qian, Zijun; Zhou, Jianping; Ni, Lei; Feng, Yun; Gao, Beili